Insider: A former Harvard chemist just raised $178 million for a biotech startup that plans to treat previously untreatable cancers
Read More
Archive for Fog In The News
PharmaVOICE 100: WeiQing Zhou
Read More
FierceBiotech: Biopharma begins to hand AI the keys to the research car
Read More
Endpoints: Harvard’s Gregory Verdine has big ambitions for his miniprotein ‘braces’ — and now $107M to guide them to the clinic
Read More
Cambridge Discovery Park Building 400-500 Will be New Headquarters for FogPharma and LifeMine Therapeutics
Read More
FierceBiotech: FogPharma collects $66M to advance cell-penetrating cancer inhibitor
Read More
Endpoints: His way: Greg Verdine is building a new kind of drug, with backing from a different kind of investor
Read More